| Literature DB >> 33573335 |
Gisella Figlioli1, Arcangela De Nicolo2, Irene Catucci1, Siranoush Manoukian3, Bernard Peissel3, Jacopo Azzollini3, Benedetta Beltrami3, Bernardo Bonanni4, Mariarosaria Calvello4, Davide Bondavalli4, Barbara Pasini5,6, Francesca Vignolo Lutati6, Paola Ogliara6, Monica Zuradelli7, Valeria Pensotti8, Giovanna De Vecchi8, Sara Volorio8, Paolo Verderio9, Sara Pizzamiglio9, Giuseppe Matullo5,6, Serena Aneli5, Giovanni Birolo5, Federica Zanardi10, Carlo Tondini11, Alberto Zambelli11, Luca Livraghi11,12, Michela Franchi11, Paolo Radice13, Paolo Peterlongo1.
Abstract
Germline pathogenic variants (PVs) in the BRCA1 or BRCA2 genes cause high breast cancer risk. Recurrent or founder PVs have been described worldwide including some in the Bergamo province in Northern Italy. The aim of this study was to compare the BRCA1/2 PV spectra of the Bergamo and of the general Italian populations. We retrospectively identified at five Italian centers 1019 BRCA1/2 PVs carrier individuals affected with breast cancer and representative of the heterogeneous national population. Each individual was assigned to the Bergamo or non-Bergamo cohort based on self-reported birthplace. Our data indicate that the Bergamo BRCA1/2 PV spectrum shows less heterogeneity with fewer different variants and an average higher frequency compared to that of the rest of Italy. Consistently, four PVs explained about 60% of all carriers. The majority of the Bergamo PVs originated locally with only two PVs clearly imported. The Bergamo BRCA1/2 PV spectrum appears to be private. Hence, the Bergamo population would be ideal to study the disease risk associated with local PVs in breast cancer and other disease-causing genes. Finally, our data suggest that the Bergamo population is a genetic isolate and further analyses are warranted to prove this notion.Entities:
Keywords: BRCA1; BRCA2; Bergamo province; Italy; breast cancer; pathogenic variants; spectrum
Year: 2021 PMID: 33573335 DOI: 10.3390/cancers13030532
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639